LncRNACASC9 promotes proliferation, metastasis, and cell cycle inovarian carcinoma cells through cyclinG1/TP53/MMP7 signaling

References

• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–386.
   PubMed Web of Science ®Google Scholar
• Goff BA, Mandel LS, Melancon CH, et al. Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. Jama. 2004;291(22):2705–2712.
   PubMed Web of Science ®Google Scholar
• Moore K, Colombo N, Scambia G, et al. Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer. N Engl J Med. 2018;379(26):2495–2505.
   PubMed Web of Science ®Google Scholar
• Kommoss S, Gilks CB, A. du Bois, F. Kommoss. Ovarian carcinoma diagnosis: the clinical impact of 15 years of change. British. J Cancer. 2016;115(8):993–999.
   Web of Science ®Google Scholar
• Reid BM, Permuth JB, Sellers TA. Epidemiology of ovarian cancer: a review. Cancer Biol Med. 2017;14(1):9–32.
   PubMed Web of Science ®Google Scholar
• Cortez AJ, Tudrej P, Kujawa KA, et al. Advances in ovarian cancer therapy. Cancer Chemother Pharmacol. 2018;81(1):17–38.
   PubMed Web of Science ®Google Scholar
• Ip JY, Nakagawa S. Long non-coding RNAs in nuclear bodies. Dev Growth Differ. 2012;54(1):44–54.
   PubMed Web of Science ®Google Scholar
• Chen YG, Satpathy AT, Chang HY. Gene regulation in the immune system by long noncoding RNAs. Nat Immunol. 2017;18(9):962–972.
   PubMed Web of Science ®Google Scholar
• Lee JT. Epigenetic regulation by long noncoding RNAs. Science. 2012;338(6113):1435–1439.
   PubMed Web of Science ®Google Scholar
• Kung JT, Colognori D, Lee JT. Long noncoding RNAs: past, present, and future. Genetics. 2013;193(3):651–669.
   PubMed Web of Science ®Google Scholar
• Liu G, Hu X, Zhou G. Long non-coding RNA OR3A4 promotes proliferation and migration in breast cancer. Biomed Pharmacother. 2017;96:426–433.
   PubMed Web of Science ®Google Scholar
• Shi D, Wu F, Mu S, et al. LncRNA AFAP1-AS1 promotes tumorigenesis and epithelial-mesenchymal transition of osteosarcoma through RhoC/ROCK1/p38MAPK/Twist1 signaling pathway. J Exp Clin Cancer Res. 2019;38(1):375.
   PubMed Web of Science ®Google Scholar
• Cheng Y. FEZF1-AS1 is a key regulator of cell cycle, epithelial-mesenchymal transition and Wnt/β-catenin signaling in nasopharyngeal carcinoma cells. Biosci Rep. 2019;39(1). DOI:10.1042/BSR20180906
   Google Scholar
• Liang Y, Chen X, Wu Y, et al. LncRNA CASC9 promotes esophageal squamous cell carcinoma metastasis through upregulating LAMC2 expression by interacting with the CREB-binding protein. Cell Death Differ. 2018;25(11):1980–1995.
   PubMed Web of Science ®Google Scholar
• Luo K, Geng J, Zhang Q, et al. LncRNA CASC9 interacts with CPSF3 to regulate TGF-β signaling in colorectal cancer. J Exp Clin Cancer Res. 2019;38(1):249.
   PubMedGoogle Scholar
• Yang F, Qin Y, Lv J, et al. Silencing long non-coding RNA Kcnq1ot1 alleviates pyroptosis and fibrosis in diabetic cardiomyopathy. Cell Death Dis. 2018;9(10):1000.
   PubMedGoogle Scholar
• Morimoto A, Kannari M, Tsuchida Y, et al. An HNF4α-microRNA-194/192 signaling axis maintains hepatic cell function. J Biol Chem. 2017;292(25):10574–10585.
   PubMed Web of Science ®Google Scholar
• Liu K, Zhao D, Wang D. LINC00528 regulates myocardial infarction by targeting the miR-143-3p/COX-2 axis. Bioengineered. 2020;11(1):11–18.
   PubMed Web of Science ®Google Scholar
• Niu Y, Ma F, Huang W, et al. Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2. Mol Cancer. 2017;16(1):5.
   PubMedGoogle Scholar
• Cheng Q, Zhang M, Zhang M, et al. Long non-coding RNA LOC285194 regulates vascular smooth muscle cell apoptosis in atherosclerosis. Bioengineered. 2020;11(1):53–60.
   PubMed Web of Science ®Google Scholar
• Tong L, Tang C, Cai C, et al. Upregulation of the microRNA rno-miR-146b-5p may be involved in the development of intestinal injury through inhibition of Kruppel-like factor 4 in intestinal sepsis. Bioengineered. 2020;11(1):1334–1349.
   PubMed Web of Science ®Google Scholar
• Vanzyl EJ, Rick KRC, Blackmore AB, et al. Flow cytometric analysis identifies changes in S and M phases as novel cell cycle alterations induced by the splicing inhibitor isoginkgetin. PLoS One. 2018;13(1):e0191178.
   PubMed Web of Science ®Google Scholar
• Chen J, Yu Y, Li H, et al. Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer. Mol Cancer. 2019;18(1):33.
   PubMed Web of Science ®Google Scholar
• Hua Q, Jin M, Mi B, et al. LINC01123, a c-Myc-activated long non-coding RNA, promotes proliferation and aerobic glycolysis of non-small cell lung cancer through miR-199a-5p/c-Myc axis. J Hematol Oncol. 2019;12(1):91.
   PubMed Web of Science ®Google Scholar
• Lengyel E. Ovarian cancer development and metastasis. Am J Pathol. 2010;177(3):1053–1064.
   PubMed Web of Science ®Google Scholar
• Wang JY, Lu AQ, Chen LJ. LncRNAs in ovarian cancer. Clin Chim Acta. 2019;490:17–27.
   PubMed Web of Science ®Google Scholar
• Fu LL, Li CJ, Xu Y, et al. Role of lncRNAs as novel biomarkers and therapeutic targets in ovarian cancer. Crit Rev Eukaryot Gene Expr. 2017;27(2):183–195.
   PubMed Web of Science ®Google Scholar
• Tripathi MK, Doxtater K, Keramatnia F, et al. Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes. Drug Discov Today. 2018;23(9):1635–1643.
   PubMed Web of Science ®Google Scholar
• Liu H, Li C, Yang J, et al. Long noncoding RNA CASC9/miR-519d/STAT3 positive feedback loop facilitate the glioma tumourigenesis. J Cell Mol Med. 2018;22(12):6338–6344.
   PubMed Web of Science ®Google Scholar
• Li X, Chen B, Chi D, et al. lncRNA CASC9 regulates cell migration and invasion in hemangioma endothelial cells by targeting miR-125a-3p/Nrg1. Onco Targets Ther. 2019;12:423–432.
   PubMed Web of Science ®Google Scholar
• Pan Z, Mao W, Bao Y, et al. The long noncoding RNA CASC9 regulates migration and invasion in esophageal cancer. Cancer Med. 2016;5(9):2442–2447.
   PubMed Web of Science ®Google Scholar
• Shao G, Wang M, Fan X, et al. Ji, lncRNA CASC9 positively regulates CHK1 to promote breast cancer cell proliferation and survival through sponging the miR‑195/497 cluster. Int J Oncol. 2019;54:1665–1675.
   PubMed Web of Science ®Google Scholar
• Zhou J, Xiao H, Yang X, et al. Long noncoding RNA CASC9.5 promotes the proliferation and metastasis of lung adenocarcinoma. Sci Rep. 2018;8(1):37.
   PubMedGoogle Scholar
• Zhan Y, Zhang L, Yu S, et al. Long non-coding RNA CASC9 promotes tumor growth and metastasis via modulating FZD6/Wnt/β-catenin signaling pathway in bladder cancer. J Exp Clin Cancer Res. 2020;39(1):136.
   PubMed Web of Science ®Google Scholar
• Liu L, Zhang Y, Wang J, et al. Long non-coding RNA CASC9 knockdown inhibits the progression of nasopharyngeal carcinoma by regulating miR-145. Int J Clin Exp Pathol. 2019;12:4024–4033.
   PubMed Web of Science ®Google Scholar
• Hu X, Li Y, Kong D, et al. Long noncoding RNA CASC9 promotes LIN7A expression via miR-758-3p to facilitate the malignancy of ovarian cancer. J Cell Physiol. 2019;234(7):10800–10808.
   PubMed Web of Science ®Google Scholar
• Liu D, Yu X, Wang S, et al. The gain and loss of long noncoding RNA associated-competing endogenous RNAs in prostate cancer. Oncotarget. 2016;7(35):57228–57238.
   PubMedGoogle Scholar
• Li Y, Li S, Luo Y, et al. LncRNA PVT1 regulates chondrocyte apoptosis in osteoarthritis by acting as a sponge for miR-488-3p. DNA Cell Biol. 2017;36(7):571–580.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Lu G, Ke X, et al. miR-488 acts as a tumor suppressor gene in gastric cancer. Tumour Biol. 2016;37(7):8691–8698.
   PubMedGoogle Scholar
• Yang Z, Feng Z, Gu J, et al. microRNA-488 inhibits chemoresistance of ovarian cancer cells by targeting Six1 and mitochondrial function. Oncotarget. 2017;8(46):80981–80993.
   PubMedGoogle Scholar
• Ye XX, Liu CB, Chen JY, et al. The expression of cyclin G in nasopharyngeal carcinoma and its significance. Clin Exp Med. 2012;12(1):21–24.
   PubMed Web of Science ®Google Scholar
• Russell P, Hennessy BT, Li J, et al. Cyclin G1 regulates the outcome of taxane-induced mitotic checkpoint arrest. Oncogene. 2012;31(19):2450–2460.
   PubMed Web of Science ®Google Scholar
• Jiang L, Liu R, Wang Y, et al. The role of Cyclin G1 in cellular proliferation and apoptosis of human epithelial ovarian cancer. J Mol Histol. 2015;46(3):291–302.
   PubMed Web of Science ®Google Scholar
• Xu Y, Zhang Q, Miao C, et al. CCNG1 (Cyclin G1) regulation by mutant-P53 via induction of Notch3 expression promotes high-grade serous ovarian cancer (HGSOC) tumorigenesis and progression. Cancer Med. 2019;8(1):351–362.
   PubMed Web of Science ®Google Scholar
• Ohtsuka T, Jensen MR, Kim HG, et al. The negative role of cyclin G in ATM-dependent p53 activation. Oncogene. 2004;23(31):5405–5408.
   PubMed Web of Science ®Google Scholar
• Al-Alem LF, McCord LA, Southard RC, et al. Activation of the PKC pathway stimulates ovarian cancer cell proliferation, migration, and expression of MMP7 and MMP10. Biol Reprod. 2013;89(3):73.
   PubMed Web of Science ®Google Scholar